Cargando…

Lipoprotein(a): A Promising Marker for Residual Cardiovascular Risk Assessment

Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and mortality worldwide, although optimal medical therapy has been prescribed for primary and secondary preventions. Residual cardiovascular risk for some population groups is still considerably high although targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Anping, Li, Liwen, Zhang, Ying, Mo, Yujin, Mai, Weiyi, Zhou, Yingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819768/ https://www.ncbi.nlm.nih.gov/pubmed/24249942 http://dx.doi.org/10.1155/2013/563717

Ejemplares similares

Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
por: Cai, Anping, et al.
Publicado: (2013)

Baseline LDL-C and Lp(a) Elevations Portend a High Risk of Coronary Revascularization in Patients after Stent Placement
por: Cai, Anping, et al.
Publicado: (2013)

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017)

Rho-GTPase and Atherosclerosis: Pleiotropic Effects of Statins
por: Cai, Anping, et al.
Publicado: (2015)

Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival via the SDF-1α/CXCR-4 Axis
por: Cai, Anping, et al.
Publicado: (2013)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Lipoprotein (a), an independent cardiovascular risk marker
por: Saeedi, Ramesh, et al.
Publicado: (2016)

Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population
por: Cai, Anping, et al.
Publicado: (2015)

Association between sociodemographic status and cardiovascular risk factors burden in community populations: implication for reducing cardiovascular disease burden
por: Cai, Anping, et al.
Publicado: (2022)

Lipoprotein (a) as a residual risk factor for atherosclerotic renal artery stenosis in hypertensive patients: a hospital-based cross-sectional study
por: Hu, Xiangming, et al.
Publicado: (2020)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins
por: Hong, Brian V., et al.
Publicado: (2023)

Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without
por: Yu, Bingyan, et al.
Publicado: (2023)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

Lipoprotein(a) is a Promising Residual Risk Factor for Long-Term Clinical Prognosis in Peripheral Arterial Disease
por: Sakata, Kimimasa, et al.
Publicado: (2022)

SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
por: Qiu, Ruofeng, et al.
Publicado: (2012)

The association of lipoprotein(a) and intraplaque neovascularization in patients with carotid stenosis: a retrospective study
por: Xia, Shuang, et al.
Publicado: (2021)

Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
por: Lawler, Patrick R., et al.
Publicado: (2017)

Glycated hemoglobin level is significantly associated with the severity of coronary artery disease in non-diabetic adults
por: Cai, Anping, et al.
Publicado: (2014)

Association of obstructive sleep apnea plus hypertension and prevalent cardiovascular diseases: A cross-sectional study
por: Wang, Ling, et al.
Publicado: (2016)

Association of anaemia and all‐cause mortality in patients with ischaemic heart failure varies by renal function status
por: Cai, Anping, et al.
Publicado: (2021)

Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
por: Uccello, Mario, et al.
Publicado: (2011)

Evidence and Uncertainties on Lipoprotein(a) as a Marker of Cardiovascular Health Risk in Children and Adolescents
por: Genovesi, Simonetta, et al.
Publicado: (2023)

Abdominal volume index trajectories and risk of diabetes mellitus: Results from the China Health and Nutrition Survey
por: Hu, Xiangming, et al.
Publicado: (2021)

Residual Risk Still Remains in Low-Density Lipoprotein
por: Hirano, Tsutomu
Publicado: (2022)

Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease
por: Ungurianu, Anca, et al.
Publicado: (2017)

Tamoxifen, serum lipoproteins and cardiovascular risk.
por: Bruning, P. F., et al.
Publicado: (1988)

Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial
por: Dunbar, Richard L., et al.
Publicado: (2015)

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

Lipoprotein (a): A Novel Cardiovascular Risk Factor
por: Kozarova, Miriam, et al.
Publicado: (2023)

Beyond LDL: Understanding Triglyceride-Rich Lipoproteins to Tackle Residual Risk
por: Gugliucci, Alejandro
Publicado: (2023)

Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
por: Taskinen, Marja-Riitta, et al.
Publicado: (2023)

Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis
por: Huang, Yuli, et al.
Publicado: (2016)

Lipoprotein (a) and cardiovascular risk factors in children and adolescents
por: Palmeira, Ástrid Camêlo, et al.
Publicado: (2013)

Lipoprotein(a): the underutilized risk factor for cardiovascular disease
por: Khan, TZ, et al.
Publicado: (2019)

Epidemiological characteristics and gender-specific differences of obstructive sleep apnea in a Chinese hypertensive population: a cross-sectional study
por: Cai, Anping, et al.
Publicado: (2017)

Plasma Oxidized Low-Density Lipoprotein Is an Independent Risk Factor in Young Patients with Coronary Artery Disease
por: Huang, Yuli, et al.
Publicado: (2011)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

The patterns of left ventricular alteration by adipose tissue distribution: implication for heart failure prevention
por: Cai, Anping, et al.
Publicado: (2021)

Age‐related alterations in cardiac and arterial structure and function in hypertensive women and men
por: Cai, Anping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r7a8ekife0hsnvmi5acttu9aqc